Gene · 2255
Papers3,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-Free Therapies: The Use of Cell Extracts to Mitigate Irradiation-Injured Salivary Glands. | Biology (Basel) | 2023 | 36829582 | PubTator, text mining | PubMed |
| Rare Variants in LRP4 Are Associated with Mesiodens, Root Maldevelopment, and Oral Exostoses in Humans. | Biology (Basel) | 2023 | 36829498 | PubTator, text mining | PubMed |
| Dysregulated lung stroma drives emphysema exacerbation by potentiating resident lymphocytes to suppress an epithelial stem cell reservoir. | Immunity | 2023 | 36822205 | PubTator, text mining | PubMed |
| Role of immediate early genes in the development of salivary gland organoids in polyisocyanopeptide hydrogels. | Front Mol Biosci | 2023 | 36818041 | PubTator, text mining | PubMed |
| Expression levels of RUNX3 and FGFR2 in peripheral blood of severe acute pancreatitis and their clinical significance. | Ann Surg Treat Res | 2023 | 36816737 | PubTator, text mining | PubMed |
| hPSC-derived lung organoids: Potential opportunities and challenges. | Heliyon | 2023 | 36814627 | PubTator, text mining | PubMed |
| Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel. | Am J Clin Pathol | 2023 | 36812376 | PubTator, text mining | PubMed |
| An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1. | Br J Cancer | 2023 | 36810913 | PubTator, text mining | PubMed |
| Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist. | J Nanobiotechnology | 2023 | 36803994 | PubTator, text mining | PubMed |
| Progress and expectation of stem cell therapy for diabetic wound healing. | World J Clin Cases | 2023 | 36793646 | PubTator, text mining | PubMed |
| Generating human blastoids modeling blastocyst-stage embryos and implantation. | Nat Protoc | 2023 | 36792779 | PubTator, text mining | PubMed |
| FGF18 promotes human lung branching morphogenesis through regulating mesenchymal progenitor cells. | Am J Physiol Lung Cell Mol Physiol | 2023 | 36791060 | PubTator, text mining | PubMed |
| Gestational Diabetes Mellitus Impedes Fetal Lung Development Through Exosome-Dependent Crosstalk Between Trophoblasts and Lung Epithelial Cells. | Int J Nanomedicine | 2023 | 36789391 | PubTator, text mining | PubMed |
| Pulmonary endogenous progenitor stem cell subpopulation: Physiology, pathogenesis, and progress. | J Intensive Med | 2023 | 36789358 | PubTator, text mining | PubMed |
| Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis. | Nat Commun | 2023 | 36788228 | PubTator, text mining | PubMed |
| First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors. | Target Oncol | 2023 | 36787089 | PubTator, text mining | PubMed |
| Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. | Mol Cancer Ther | 2023 | 36780225 | PubTator, text mining | PubMed |
| Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models. | Pharmacol Res | 2023 | 36773708 | PubTator, text mining | PubMed |
| Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer. | Oral Oncol | 2023 | 36773387 | PubTator, text mining | PubMed |
| Inflammatory Treatment Used to Mimic Osteoarthritis and Patients' Synovial Fluid Have Divergent Molecular Impact on Chondrocytes In Vitro. | Int J Mol Sci | 2023 | 36768948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2255/papers?page=28